Angle Health has announced a $600 million equity financing at a $2.7 billion valuation, marking one of the largest recent investments in AI-driven healthcare benefits. The San Francisco-based company said the round includes a $200 million Series C and a $400 million tender offer. The transaction is expected to close later this month and will support expanded access for small businesses.
Financing Structure and Investors
Vitruvian Partners led the financing, with new investor Town Hall Ventures joining existing backers Blumberg Capital, Portage Ventures, PruVen Capital and Y Combinator. The funding package includes a $200 million Series C round and a $400 million tender offer. It arrives less than ten months after the company's Series B announcement and is expected to close later this month.
Market Pressure on Small Employers
The announcement comes as employers nationwide confront the largest increase in health insurance costs in two decades. Small and midsize businesses often face limited options that are expensive, confusing and difficult for employees to navigate. Angle Health says these employers have historically had little control over costs despite employing tens of millions of Americans.
Financial Strength and Growth Metrics
Angle Health enters its next phase with 120 percent year-over-year growth and four consecutive quarters of EBITDA and GAAP net income profitability. The company now serves more than 5,000 employers in 47 states with nearly one billion dollars in annualized premium equivalents. Its median year-over-year rate increases of 5 to 7 percent compare favorably with a median increase of 18 percent for small and midsize businesses.
AI-Native Platform and Benefits
Angle Health operates an AI-native healthcare benefits platform capable of end-to-end health plan administration. Employers with as few as two employees in some states can offer customized benefits and personalized healthcare journeys. The company's Benefit Builder platform gives brokers firm underwritten quotes in minutes and real-time plan customization.
Care Delivery and Renewal Stability
Beyond its technology platform, Angle Health has expanded care delivery programs with partners to provide lower-cost access to high-cost medications, infusions, outpatient surgery and radiology. The company has also delivered some of the most stable health plan renewal rates in the market. These efforts aim to improve patient outcomes while helping employers manage rising costs.
Strategic Use of New Capital
Angle Health plans to use the capital to rebuild underlying healthcare infrastructure and invest in AI-native technology. The company will focus on seamless navigation across hyper-local, condition-specific care options. Executives said the funding will create greater transparency and better experiences for brokers, employers, employees, and clinicians.
Leadership Commentary
Ty Wang, co-founder and CEO, said access to quality healthcare should not depend on the size of the company where a person works. He noted that small businesses employ tens of millions of Americans but have historically had the fewest coverage options. Wang added that the partnership with Vitruvian brings deep expertise at the intersection of healthcare, technology and financial services.
Angle Health's new financing underscores growing investor interest in modernizing employer-sponsored healthcare through artificial intelligence. The company's profitability, growth, and stable renewal pricing distinguish it from legacy insurers in a volatile market. With this capital, Angle Health aims to expand affordable and high-quality care access for the small businesses that employ nearly half of Americans.